Based in Gothenburg Sweden, Fluicell is an innovative life science company dedicated to delivering single-cell microfluidic research tools and services for scientists worldwide. The company was founded in 2012 and provides easy-to-use research solutions in 3d single-cell bioprinting of biological tissues as well as single-cell biology and pharmacology. Fluicell is a world leader and pioneer in open-volume microfluidics for the life sciences, with customers in leading academic institutions and major pharmaceutical companies. Fluicell’s innovative technologies are supported by a strong IP and patent position. The company is listed on Nasdaq First North Growth Market since April 2018 under the Ticker FLUI
Location: Sweden, Mölndal
Employees: 11-50
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | Almi Inves... | almi.se |
| 19.12.2021 | Chalmers V... | chalmersve... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 25.10.2023 | Revolutionising Single-Cell Investigations: The Future of Bi... | Key Takeaways: Fluicell is a Swedish biotech startup revolutionizing single-cell investigations with... | eustartup.... |
| 25.01.2023 | What is the future of 3D printing? 80 additive manufacturing... | The annual 3D Printing Industry Executive Survey collects insights from analysts, academics, CEOs, a... | 3dprinting... |
| 18.02.2022 | 3D bioprinting project to deliver BRIGHTER alternative to an... | A European Union (EU) funded project is seeking to reduce animal testing within experimental medical... | 3dprinting... |